News | July 14, 2025
Emcure Pharmaceuticals successfully completes USFDA PAI of Oncology facility
Havix is a US based company engaged in the business of developing, manufacturing and supplying of various finished formulations
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
Acquisition aligns with Merck’s science-led business development strategy and expands pipeline and portfolio of treatments for cardio-pulmonary diseases
He has held senior leadership positions at Syngene International, Fujifilm Diosynth Biotechnologies, Thermo Fisher Scientific, Sartorius Stedim Biotech, and other leading organizations
The audit has been concluded with no major observations
The acquisition of Pivya is an important step in Alembic’s ability to provide branded pharmaceutical product to the US Healthcare market
ART-123 is a recombinant human thrombomodulin approved in Japan in 2008
Opaganib has shown potential in enhancing ARPI treatment by blocking multiple enzymes involved in cancer cell survival.
Subscribe To Our Newsletter & Stay Updated
